Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial
Human M Fatemi, Janine Oberyé, Biljana Popovic-Todorovic, Han Witjes, Bernadette Mannaerts, Paul Devroey, Human M Fatemi, Janine Oberyé, Biljana Popovic-Todorovic, Han Witjes, Bernadette Mannaerts, Paul Devroey
Abstract
Fifty healthy women, aged 18-39 years with no known risk of ovarian hyperstimulation were treated with 100 or 150 μg corifollitropin alfa (dependent on body weight) in a long GnRH agonist protocol. At these doses, corifollitropin alfa initiated and supported growth of a large cohort of follicles during the first week of ovarian stimulation.
Copyright © 2010. Published by Elsevier Inc.
Source: PubMed